RxDoctor Payments Data

Ramiro Mercado, MD

Family Medicine · Chicago, ILNPI 1558329276

Payments from drug & device makers

$2,415in general payments, 2019–2025

Across 102 payments — averaging $23.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$464
  • Boehringer Ingelheim$412
  • Lilly USA, LLC$321
  • Bayer$310
  • Amgen$195
  • Abbott$144
  • plus $568 from 9 others

What the payments were for

  • Food & beverage$2,37098%
  • Education$452%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,415 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$16,513
Medicare patients
44
Services billed
237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin69$81,304
TrulicityDulaglutide20$24,002
OzempicSemaglutide14$20,734
XareltoRivaroxaban12$16,053
TradjentaLinagliptin15$15,463
Tresiba Flextouch U-200Insulin Degludec23$14,616
Breo ElliptaFluticasone/Vilanterol30$12,416
Bydureon BciseExenatide Microspheres11$8,159
Incruse ElliptaUmeclidinium Bromide17$6,285
Lantus SolostarInsulin Glargine,hum.Rec.Anlog46$5,522
Rosuvastatin Calcium136$2,592
Atorvastatin Calcium353$2,216
Albuterol Sulfate HfaAlbuterol Sulfate54$1,749
Levothyroxine Sodium145$1,533
Omeprazole132$1,522

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$412$96,76784 claims
Lilly USA, LLCTrulicity$321$24,00220 claims
Novo NordiskOzempic$464$20,73414 claims
GSKBreo Ellipta, Incruse Ellipta$27$18,70147 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →